AIRS
AirSculpt Technologies, Inc.
AIRS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
AIRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
AIRS's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
AIRS PE Valuation
AIRS has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
AIRS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect AIRS's losses to grow, with revenue holding steady.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
HIMS has the edge over AIRS on the outlook, with more favorable revenue and profitability expectations.
AIRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.13 | +$0.16 |
| Q2 2026 | -$0.18 | +$0.06 |
| Q1 2026 | -$0.17 | +$0.12 |
| Q4 2025 | -$0.19 | -$0.05 |
| Q3 2025 | -$0.29 | -$0.15 |
| Q2 2025 | -$0.24 | -$0.17 |
| Q1 2025 | -$0.29 | -1550% |
| Q4 2024 | -$0.14 | -$0.06 |
AIRS is still losing money, but far less than before: $0.13 per share over the past year, against $0.29 at its worst in early 2025.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over AIRS on earnings, with more consistent year-over-year improvement.
AIRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $31.9M | -8.7% |
| Q2 2026 | $42.9M | -2.5% |
| Q1 2026 | $39.4M | 0% |
| Q4 2025 | $33.4M | -15% |
| Q3 2025 | $35M | -18% |
| Q2 2025 | $44M | -14% |
| Q1 2025 | $39.4M | -17% |
| Q4 2024 | $39.2M | -18% |
AIRS's revenue has slid since its 2023 peak: $32M last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | +15 points |
| Q2 2026 | -0.1% | -1.9 points |
| Q1 2026 | -4.6% | -0.5 points |
| Q4 2025 | -3% | +7.5 points |
| Q3 2025 | -28% | -19 points |
| Q2 2025 | 1.8% | +12 points |
| Q1 2025 | -4% | -27 points |
| Q4 2024 | -11% | -14 points |
AIRS's operating margin was โ13% last quarter, up 15 points from the same quarter a year ago, near the bottom of its range since 2020.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over AIRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over AIRS on profitability, with a higher operating margin.
AIRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.7M | -$3.3M |
| Q2 2026 | -$1.5M | -131% |
| Q1 2026 | $5.2M | +$6.3M |
| Q4 2025 | -$2.6M | -$1.8M |
| Q3 2025 | -$405K | +$2.7M |
| Q2 2025 | $4.7M | +$5.3M |
| Q1 2025 | -$1M | -157% |
| Q4 2024 | -$815K | -127% |
AIRS has burned cash in six of the last eight quarters: โ$3M over the past year, against $2M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over AIRS on cash generation, producing positive trailing cash flow while its opponent burns cash.
AIRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q1 2026 | 35.7x | High |
| Q4 2025 | 39.0x | High |
| Q2 2025 | 12.3x | High |
| Q4 2024 | 6.1x | High |
| Q3 2024 | 4.2x | High |
| Q2 2024 | 3.1x | Elevated |
| Q1 2024 | 2.0x | Moderate |
AIRS's net debt is about 4.3 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
AIRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.5 | Neutral |
| Stochastic | 7.2 | Oversold |
AIRS's weekly RSI is 32 (neutral) and its Stochastic is 7 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
AIRS PE vs Healthcare Sector
| Metric | AIRS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
AIRS has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
AIRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.35 | 47% below |
| 20 week MA | $2.74 | 74% below |
| 50 week MA | $2.95 | 76% below |
| 100 week MA | $4.09 | 82% below |
| 200 week MA | $5.09 | 86% below |
AIRS is in a downtrend: it's below all five of its weekly moving averages, and 86% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
AIRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.9 | $14.5 | -8.7% |
| 2022 | $14.5 | $3.32 | -77% |
| 2023 | $3.32 | $7.49 | +126% |
| 2024 | $7.49 | $5.58 | -26% |
| 2025 | $5.58 | $2.03 | -64% |
| 2026 YTD | $2.03 | $0.72 | -65% |
AIRS's yearly returns have swung widely, from +126% in 2023 to โ77% in 2022. It's down 65% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over AIRS on returns for 2026, with the stronger performance.